4 hours ago
Guggenheim Ups Eli Lilly (LLY) Price Target to $1,273 on Pipeline Strength
Guggenheim raises Eli Lilly (LLY) price target to $1,273, citing strong tirzepatide growth and retatrutide pipeline potential. Q2 earnings expected August 5.
The post Guggenheim Ups Eli Lilly (LLY) Price Target to $1,273 on Pipeline Strength appeared first on Blockonomi.
Source: Blockonomi →Related News
- 3 hours ago
Verizon (VZ) Stock: Telecom Giant Backs Small Business Growth Through Super Pitc...
- 4 hours ago
Market Recap: Semiconductor Selloff, Energy Surge, and Q2 Earnings Underway
- 4 hours ago
SpaceX (SPCX) Stock Drops 5.58% Following FAA Green Light for Starship Flight 13
- 4 hours ago
Marvell Technology (MRVL) Plunges 8% Amid Chip Stock Rout
- 4 hours ago
JPMorgan Sees 25% Upside Potential for MDA Space (MDA) Stock Following €567M CLS...
